Dr. Lisa Fronek, Mohs Surgeon

The Mohs Micrographic Skin Cancer Surgery is a specialized skin cancer treatment created particularly for skin cancers that appear on the head and neck. It offers the highest possible cure rates while removing as little normal skin as possible.

Dr. Lisa Fronek specializes in skin cancer diagnosis and Mohs Skin Cancer Surgery.

What is Mohs Micrographic Skin Cancer Surgery?

The Mohs Micrographic Skin Cancer Surgery procedure begins by thoroughly numbing the area with a local anesthetic. Then all visible skin cancer is removed and a very thin layer of surrounding skin is taken to check for any remaining skin cancer cells that are otherwise invisible to the naked eye. This layer is processed by a technician and examined under a microscope by the micrographic surgeon. The location of any remaining cancer is carefully mapped on a diagram and then removed in a thin layer. This tissue is also examined under the microscope and the process is repeated as many times as necessary until all the cancer cells have been completely removed.

By using these techniques, the micrographic surgeon is able to locate and remove even the smallest cancer roots without taking large and unnecessary amounts of normal uninvolved skin.

What are the chances of curing my skin cancer?

The Mohs Micrographic Skin Cancer Surgery offers the highest available cure rate of all skin cancer treatments. Over 96% of skin cancers are cured following the Mohs Micrographic Skin Cancer Surgery even if other treatments have failed. 99% are cured if the cancer has not been treated before. Other methods of treatment average only a 60-85% chance of cure if previous skin cancer treatments have failed.

SRT-100

Soft, smooth, healthy skin is coveted at every age. But if you are one of the millions of people who suffer from non-melanoma skin cancer or unsightly keloid scarring, you may be self-conscious about your appearance and feel like you have to keep your skin covered.

Now there’s a non-surgical treatment that could be right for you—the SRT-100™by Sensus Healthcare.

Using a precise, calibrated dose of Superficial Radiotherapy (SRT) that only penetrates five millimeters below the skin’s surface, this minimally invasive treatment effectively removes both basal and squamous cell carcinoma (non-melanoma skin cancer), and unattractive keloids. Feel confident about your skin with the SRT-100™.

Skin cancer is on the rise. Nearly four million people are diagnosed with basal and squamous cell carcinoma (non-melanoma skin cancer) each year in the United States. If you’re one of them, you know traditional treatments like Mohs surgery are often used. While surgery is an appropriate option, there are times when a non-surgical alternative like SRT is desired. This amazing non-surgical treatment delivers a remarkable cure rate-98 percent for non-melanoma skin cancer.

Performed right in the doctor’s office, each treatment is painless and only takes a few minutes. The SRT-100™ can be used to treat lesions on the arms, legs, back and trunk. It works especially well on skin cancers located on the head and neck where nearly 80 percent of all skin cancer occurs-especially along the fold of the nose, eyelids, lips, corner of the mouth and the lining of the ear.

KELOID TREATMENT THAT RESTORES YOUR SKIN’S SENSUAL BEAUTY.

For nearly 11 million people afflicted by these unsightly and sometimes painful growths, keloids don’t just scar the skin; they can scar a person’s confidence. The SRT-100™ by Sensus Healthcare is giving countless keloid sufferers new hope and confidence.

Whether you suffer from keloids caused by surgery, acne, chicken pox, piercing or burns, the SRT-100™ can help rid you of these non-malignant tumors caused by skin trauma. The SRT-100™ is also a good treatment option for individuals who are genetically prone to keloids-including African Americans, Latinos and Asians. In fact, patients who undergo treatment with the SRT-100™ after excision of the scar tisue enjoy cure rates of 95% and higher.


ENJOY SENSATIONAL BENEFITS


With cure ratessimilar to surgery, the SRT-100™ provides patients and physicians with safe and effective basal cell and squamous cell carcinoma treatment. The SRT-100™ offers many